| 3D-QSAR, molecular dynamics simulations and molecular docking studies of benzoxazepine moiety as mTOR inhibitor for the treatment of lung cancer U Chaube, D Chhatbar, H Bhatt Bioorganic & medicinal chemistry letters 26 (3), 864-874, 2016 | 45 | 2016 |
| CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of … DM Chhatbar, UJ Chaube, VK Vyas, HG Bhatt Computational Biology and Chemistry 80, 351-363, 2019 | 32 | 2019 |
| 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors U Chaube, H Bhatt Molecular Diversity 21, 741-759, 2017 | 19 | 2017 |
| Beneficial effect of silymarin in pressure overload induced experimental cardiac hypertrophy B Sharma, U Chaube, BM Patel Cardiovascular Toxicology 19, 23-35, 2019 | 15 | 2019 |
| Design and development of Tetrahydro-Quinoline derivatives as dual mTOR-C1/C2 inhibitors for the treatment of lung cancer UJ Chaube, R Rawal, AB Jha, B Variya, HG Bhatt Bioorganic Chemistry 106, 104501, 2021 | 13 | 2021 |
| ChemistrySelect S Shaw, R Dey, H Bhatt, B Patel, S Patel, N Dixit, U Chaube | 8 | 2019 |
| Design and synthesis of potent N-phenylpyrimidine derivatives for the treatment of skin cancer UJ Chaube, VK Vyas, HG Bhatt RSC advances 6 (13), 10285-10297, 2016 | 8 | 2016 |
| A hypothesis on designing strategy of effective RdRp inhibitors for the treatment of SARS-CoV-2 U Chaube, BD Patel, HG Bhatt 3 Biotech 13 (1), 12, 2023 | 3 | 2023 |
| Tetrahydroquinoline: an efficient scaffold as mTOR inhibitor for the treatment of lung cancer U Chaube, R Dey, S Shaw, BD Patel, HG Bhatt Future Medicinal Chemistry 14 (23), 1789-1809, 2022 | 3 | 2022 |
| Discovery of novel CaMK-II inhibitor for the possible mitigation of arrhythmia through pharmacophore modelling, virtual screening, molecular docking, and toxicity prediction N Parekh, S Lakhani, A Patel, D Oza, B Patel, R Yadav, U Chaube Artificial Intelligence Chemistry 1 (2), 100009, 2023 | 2 | 2023 |
| Identification of potent, non-toxic, selective CDK2 inhibitor through the pharmacophore-based scaffold hopping, molecular dynamics simulation-assisted molecular docking study … U Chaube, H Bhatt Structural Chemistry 33 (6), 1895-1905, 2022 | 2 | 2022 |
| Homology modeling, binding site identification, molecular docking and molecular dynamics simulation study of emerging and promising drug target of Wnt signaling–Human Porcupine … V Goswami, D Patel, S Rohit, U Chaube, B Patel Results in Chemistry, 101482, 2024 | | 2024 |
| Designing of target‐specific N‐substituted tetrahydroquinoline derivatives as potent mTOR inhibitors via integrated structure‐guided computational approaches S Shaw, R Dey, H Bhatt, B Patel, S Patel, N Dixit, U Chaube ChemistrySelect 9 (7), e202303291, 2024 | | 2024 |
| Design, Synthesis, and In-Vitro Biological Evaluation of Novel THQ Derivatives as Anticancer Agents. R Dey, S Shaw, B Patel, H Bhatt, S Patel, N Dixit, U Chaube Malaysian Journal of Medicine & Health Sciences 20, 2024 | | 2024 |
| Just another WordPress site Menu UJ Chaube, R Rawal, AB Jha, B Variya, HG Bhatt | | 1920 |
| Synthesis, Biological Screening, and Binding Mode Analysis of Some N-Substituted Tetrahydroquinoline Analogs as Apoptosis Inducers and Anticancer Agents R Dey, S Shaw, H Bhatt, R Yadav, B Patel, U Chaube Biological Screening, and Binding Mode Analysis of Some N-Substituted …, 0 | | |
| Results in Chemistry V Goswami, D Patel, S Rohit, U Chaube, B Patel | | |
| Ftase Signal DM Chhatbar, UJ Chaube, VK Vyas, HG Bhatt, C CoMFA, ... | | |
Dr. Hardik BhattInstitute of Pharmacy, Nirma UniversityVerified email at nirmauni.ac.in
